15 research outputs found
Lipid droplets and their interactions with other organelles in liver diseases
Lipid droplets are cellular organelles used for lipid storage with a hydrophobic core of neutral lipids enclosed by a phospholipid monolayer. Besides presenting as giant single organelles in fat tissue, lipid droplets are also widely present as a multitude of small structures in hepatocytes, where they play key roles in health and disease of the liver. In addition to lipid storage, lipid droplets are also directly involved in lipid metabolism, membrane biosynthesis, cell signaling, inflammation, pathogen-host interaction and cancer development. In addition, they interact with other cellular organelles to regulate cellular biology. It is fair to say that the exact functions of lipid droplets in cellular physiology remain largely obscure. Thus prompted, here we aim to analyze the corpus of contemporary biomedical literature to create a framework as to how the role of lipid droplets in hepatocyte physiology and pathophysiology should be understood. The resulting framework should help understanding the interaction of lipid droplets with other organelles in important liver diseases, including fatty liver disease, viral hepatitis and liver cancer and direct further research directions
PI3K-Akt-mTOR axis sustains rotavirus infection via the 4E-BP1 mediated autophagy pathway and represents an antiviral target
Rotavirus infection is a major cause of severe dehydrating diarrhea in infants younger than 5Â y old and in particular cases of immunocompromised patients irrespective to the age of the patients. Although vaccines have been developed, an
The global epidemiology of hepatitis E virus infection: A systematic review and meta-analysis
Background and aims: Hepatitis E virus (HEV), as an emerging zoonotic pathogen, is a leading cause of acute viral hepatitis worldwide, with a high risk of developing chronic infection in immunocompromised patients. However, the global epidemiology of HEV infection has not been comprehensively assessed. This study aims to map the global prevalence and identify the risk factors of HEV infection by performing a systematic review and meta-analysis. Methods: A systematic searching of articles published in Medline, Embase, Web of science, Cochrane and Google scholar databases till July 2019 was conducted to identify studies with HEV prevalence data. Pooled prevalence among different countries and continents was estimated. HEV IgG seroprevalence of subgroups was compared and risk factors for HEV infection were evaluated using odd ratios (OR). Results: We identified 419 related studies which comprised of 1Â 519Â 872 individuals. A total of 1Â 099Â 717 participants pooled from 287 studies of general population estimated a global anti-HEV IgG seroprevalence of 12.47% (95% CI 10.42-14.67; I2Â =Â 100%). Notably, the use of ELISA kits from different manufacturers has a substantial impact on the global estimation of anti-HEV IgG seroprevalence. The pooled estimate of anti-HEV IgM seroprevalence based on 98 studies is 1.47% (95% CI 1.14-1.85; I2Â =Â 99%). The overall estimate of HEV viral RNA-positive rate in general population is 0.20% (95% CI 0.15-0.25; I2Â =Â 98%). Consumption of raw meat (PÂ =.0001), exposure to soil (PÂ <.0001), blood transfusion (PÂ =.0138), travelling to endemic areas (PÂ =.0244), contacting with dogs (PÂ =.0416), living in rural areas (PÂ =.0349) and receiving education less than elementary school (PÂ <.0001) were identified as risk factors for anti-HEV IgG positivity. Conclusions: Globally, approximately 939Â million corresponding to 1 in 8 individuals have ever experienced HEV infection. 15-110Â million individuals have recent or ongoing HEV infection. Our study highlights the substantial burden of HEV infection and calls for increasing routine screening and preventive measures
Direct-acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta-analysis
Background: Comprehensive evaluation of safety and efficacy of different combinaâ
tions of directâacting antivirals (DAAs) in liver transplant recipients with genotype 1
(GT1) hepatitis C virus (HCV) recurrence remains limited. Therefore, we performed
this systematic review and metaâanalysis in order to evaluate the clinical outcome of
DAA treatment in liver transplant patients with HCV GT1 recurrence.
Methods: Studies were included if they contained information of 12 weeks sustained
virologic response (SVR12) after DAA treatment completion as well as treatment reâ
lated complications for liver transplant recipients with GT1 HCV recurrence.
Results: We identified 16 studies comprising 885 patients. The overall pooled estiâ
mate proportion of SVR12 was 93% (95% confidence interval (CI): 0.89, 0.96), with
moderate heterogeneity observed (Ï
2 = 0.01, P < 0.01, I
2
=75%). High tolerability was
observed in liver transplant recipients reflected by serious adverse events (sAEs) with
pooled estimate proportion of 4% (95% CI: 0.01, 0.07; Ï2 = 0.02, P < 0.01, I
2 = 81%).
For subgroup analysis, a total of five different DAA regimens were applied for treating
these patients. Sofosbuvir/Ledipasvir (SOF/LDV) led the highest pooled estimate
SVR12 proportion, followed by Paritaprevir/Ritonavir/Ombitasivir/Dasabuvir (PrOD),
Daclatasvir (DCV)/Simeprevir (SMV) ± Ribavirin (RBV), and SOF/SMV ± RBV,
Asunaprevir (ASV)/DCV. There was a tendency for favoring a higher pooled SVR12
proportion in patients with METAVIR Stage F0âF2 of 97% (95% CI: 0.93, 0.99) comâ
pared to 85% (95% CI: 0.79, 0.90) for stage F3âF4 (P < 0.01). There was no significant
difference between LT recipients treated with or without RBV (P = 0.23).
Conclusions: Directâacting antiviral treatment is highly effective and wellâtolerated
in liver transplant recipients with recurrent GT1 HCV infection
Pregnane X receptor activation constrains mucosal NF-ÎșB activity in active inflammatory bowel disease
Background The Pregnane X Receptor (PXR) is a principal signal transducer in mucosal responses to xenobiotic stress. It is well-recognized that inflammatory bowel disease is accompanied by xenobiotic stress, but the importance of the PXR in limiting inflammatory responses in inflammatory bowel disease remains obscure at best. Methods We stimulate a total of 106 colonic biopsies from 19 Crohnâs disease patients with active disease, 36 colonic biopsies from 8 control patients, colonic organo
Dichotomal functions of phosphorylated and unphosphorylated STAT1 in hepatocellular carcinoma
Abstract: Interferons (IFNs) with antiviral and immune-stimulatory functions have been widely used in prevention and treatment of hepatocellular carcinoma (HCC). Signal transducer and activator of transcription 1 (STAT1) is a key element of the IFN signaling, and the function of STAT1 is critically determined by its phosphorylation state. This study aims to understand the functions of phosphorylated (p-) and unphosphorylated (u-) STAT1 in HCC. We found that u-STAT1 is significantly elevated in patient HCC tumor tissues and predominantly expressed in cytoplasm; while p-STAT1 is absent. Loss of u-STAT1 potently arrested cell cycle and inhibited cell growth in HCC cells. Induction of p-STAT1 by IFN-α treatment effectively triggers the expression of interferon-stimulated genes (ISGs), but has moderate effect on HCC cell growth. Interestingly, both u-STAT1 and p-STAT1 are induced by IFN-α, through with distinct time-dependent process. Furthermore, the ISG induction patterns mediated by p-STAT1 and u-STAT1 are also distinct. Importantly, artificial blocking of the induction of u-STAT1, but not p-STAT1, sensitizes HCC cells to treatment of IFNs. Therefore, p-STAT1 and u-STAT1 exert dichotomal functions and coordinately regulate the responsiveness to IFN treatment in HCC. Key Messages: STAT1 is upregulated and predominantly presented as u-STAT1 in HCC, while p-STAT1 is absent.U-STAT1 sustains but p-STAT1 inhibits HCC growth.The dynamic change of phosphorylation state of STAT1 control the responsiveness to IFN treatment
PI3K-Akt-mTOR axis sustains rotavirus infection via the 4E-BP1 mediated autophagy pathway and represents an antiviral target
Rotavirus infection is a major cause of severe dehydrating diarrhea in infants younger than 5Â y old and in particular cases of immunocompromised patients irrespective to the age of the patients. Although vaccines have been developed, an
Smoothened-dependent and -independent pathways in mammalian noncanonical Hedgehog signaling
Hedgehog proteins are pivotal morphogens acting through a canonical pathway involving first activation of ligand binding to Patched followed by alleviation of Smoothened receptor inhibition, leading to activation of Gli transcription factors. Noncanonical Hedgehog signaling remains poorly characterized but is thought to be mainly dependent on Smoothened. However, Smoothened inhibitors have yielded only partial success in combating Hedgehog signal transduction-dependent cancer, suggesting that noncanonical Smoothened-independent pathways also are clinically relevant. Moreover, several Smoothened-dependent effects (e.g. neurite projection) do not require transcriptional activation, further suggesting biological importance of noncanonical Smoothened-dependent pathways. We comprehensively characterized the cellular kinome in Hedgehog-challenged murine WT and Smoothened(-/-) fibroblasts as well as Smoothened agonist-stimulated cells. A peptide assay-based kinome analysis (in which cell lysates are used to phosphorylate specific kinase substrates), along with endocytosis, Lucifer Yellow-based, and immunoblotting assays, identified an elaborate signaling network of both Smoothened-dependent and -independent pathways that mediates actin reorganization through Src-like kinases, activates various proinflammatory signaling cascades, and concomitantly stimulates Wnt and Notch signaling while suppressing bone morphogenetic protein (BMP) signaling. The contribution of noncanonical Smoothened-independent signaling to the overall effects of Hedgehog on cellular physiology appears to be much larger than previously envisioned and may explain the transcriptionally independent effects of Hedgehog signaling on cytoskeleton. The observation that Patched-dependent, Smoothened-independent, noncanonical Hedgehog signaling increases Wnt/Notch signaling provides a possible explanation for the failure of Smoothened antagonists in combating Hedgehog-dependent but Smoothened inhibitor-resistant cancer. Our findings suggest that inhibiting Hedgehog-Patched interaction could result in more effective therapies as compared with conventional Smoothened-directed therapies
Smoothened-dependent and -independent pathways in mammalian noncanonical Hedgehog signaling
Hedgehog proteins are pivotal morphogens acting through a canonical pathway involving first activation of ligand binding to Patched followed by alleviation of Smoothened receptor inhibition, leading to activation of Gli transcription factors. Noncanonical Hedgehog signaling remains poorly characterized but is thought to be mainly dependent on Smoothened. However, Smoothened inhibitors have yielded only partial success in combating Hedgehog signal transduction-dependent cancer, suggesting that noncanonical Smoothened-independent pathways also are clinically relevant. Moreover, several Smoothened-dependent effects (e.g. neurite projection) do not require transcriptional activation, further suggesting biological importance of noncanonical Smoothened-dependent pathways. We comprehensively characterized the cellular kinome in Hedgehogchallenged murine WT and Smoothened-/- fibroblasts as well as Smoothened agonist-stimulated cells. A peptide assay-based kinome analysis (in which cell lysates are used to phosphorylate specific kinase substrates), along with endocytosis, Lucifer Yellow-based, and immunoblotting assays, identified an elaborate signaling network of both Smoothened-dependent and -independent pathways that mediates actin reorganization through Src-like kinases, activates various proinflammatory signaling cascades, and concomitantly stimulates Wnt and Notch signaling while suppressing bone morphogenetic protein (BMP) signaling. The contribution of noncan
Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections
A tripartite transcription factor complex mediates an interferon-independent antiviral response.</jats:p